Jue. Abr 22, 2021

Latino News

Noticias de Hazleton y el mundo

Fundado el 20 de mayo de 2013

Bristol Myers Squibb to Participate in Citi’s 15th Annual BioPharma Virtual Conference

NEW YORK–(BUSINESS WIRE)–$BMY #BMSBristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Citi’s 15th Annual BioPharma Virtual Conference, which will be webcast on Tuesday, September 8, 2020. Samit Hirawat, MD, EVP, Chief Medical Officer and Rupert Vessey, MA, BM BCh, FRCP, DPhil, EVP of Research and Early Development will answer questions about the company at 12:15 p.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Contacts

Bristol Myers Squibb
Media:

media@bms.com
609-252-3345

Investor Relations:

Tim Power

609-252-7509

timothy.power@bms.com

Nina Goworek

908-673-9711

nina.goworek@bms.com